Clinical and Life Sciences · 29 September 2026 to 29 September 2026 · 1 headlines · MedPage Today
FDA Approves First Treatment for Rare Thyroid Hormone Disorder
The FDA has approved the first treatment for a rare thyroid hormone disorder.
As it ran
29 September 2026
More from US healthcare
- Fears of Payer AI Use in Auditing Loom as Providers Establish Their Own AI Tools 29 September 2026
- EliseAI nabs $350M, hits $4B valuation 29 September 2026
- Vaccine and drug policy in the midterm elections 29 September 2026
- STAT Plus: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event 29 September 2026
- STAT Plus: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property 29 September 2026
- STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal 29 September 2026
- STAT Plus: The last ‘breakthrough’ devices to get special treatment from Medicare 29 September 2026
- UniQure's Huntington's gene therapy trial 29 September 2026